ID: ALA4791530

Max Phase: Preclinical

Molecular Formula: C27H34N4O4

Molecular Weight: 478.59

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COCc1cc2cc(-n3nc(C)c4c3CC(C)(C)CC4=O)cc(N[C@H]3CC[C@H](O)CC3)c2c(=O)[nH]1

Standard InChI:  InChI=1S/C27H34N4O4/c1-15-24-22(12-27(2,3)13-23(24)33)31(30-15)19-10-16-9-18(14-35-4)29-26(34)25(16)21(11-19)28-17-5-7-20(32)8-6-17/h9-11,17,20,28,32H,5-8,12-14H2,1-4H3,(H,29,34)/t17-,20-

Standard InChI Key:  YEGYDXAGGLLELC-IRJFHVNHSA-N

Associated Targets(Human)

Heat shock protein HSP 90-beta 1689 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heat shock protein HSP 90-alpha 4115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 478.59Molecular Weight (Monoisotopic): 478.2580AlogP: 4.04#Rotatable Bonds: 5
Polar Surface Area: 109.24Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.05CX Basic pKa: 2.73CX LogP: 2.53CX LogD: 2.53
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.51Np Likeness Score: -0.66

References

1. Mishra SJ,Liu W,Beebe K,Banerjee M,Kent CN,Munthali V,Koren J,Taylor JA,Neckers LM,Holzbeierlein J,Blagg BSJ.  (2021)  The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.,  64  (3.0): [PMID:33428418] [10.1021/acs.jmedchem.0c01700]

Source